Indications for BRCA1 and BRCA2 mutation testing in hereditary breast and ovarian cancer families

Autor:	R. Schmutzler, U. Schwarz-Boeger, G. Bastert, null Bender, null Beckmann, null Caffier, null Crohns, J. Deininger, null Dietl, null Ditsch, null Distler, null Estevez-Schwarz, W. Hahn, null Herröder, null Hübbel, null Hüttner, null Jackisch, null Kandl, K. Kast, null Kuschel, null Luck, null Von Minckwitz, null nestle-Krämling, B. Prieshof, null Rensing, null Rhiem, null Schäffer, null Straub, null Untch, T. Volm, M. Kiechle
Rok vydání:	2004
Předmět:	Cancer Research endocrine system diseases medicine.diagnostic_test business.industry medicine.disease BRCA2 Mutation Germline mutation Oncology Cancer research Medicine skin and connective tissue diseases business Ovarian cancer Gene Genetic testing
Zdroj:	Journal of Clinical Oncology. 22:9720-9720
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2004.22.90140.9720
Popis:	9720 Background: Since characterization of BRCA1 and BRCA2 in 1994 1995 resp. genetic testing of these genes is possible. Germline mutations in these genes are the most common reason for hereditary...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::aa32c29cff2b994b17b9df8498701b2a https://doi.org/10.1200/jco.2004.22.90140.9720 Zobrazit plný text záznamu